Home Credit Ratings and Research Fitch Research

Fitch Ratings: Low Rating Headroom for Pharma Issuers in 2019

Published Nov 26, 2018

1503 words — Published Nov 26, 2018

Price US$ 149.00 | Buy this Report Now

About This Report

Brief Excerpt:

Fitch Ratings: Low Rating Headroom for Pharma Issuers in 2019 26 Nov 2018 10:08 AM (EST) Link to Fitch Ratings' Report(s): Fitch Ratings 2019 Outlook: Global Big Pharma & Biotech {COMPANYDESC_ORIGIN_PUBDATE}: Fitch Ratings says the rating...

Report Type:

Press Release

Ticker(s)

AMGN , BAYN , BHC , JNJ , LLY , NOT , PFE , RO , SAN , TEVA

Issuer

Valeant Pharmaceuticals International Inc.

Format:

HTML

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author

Cite this Report


MLA:	Fitch Research. "Fitch Ratings: Low Rating Headroom for Pharma Issuers in 2019" Nov 26, 2018. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Ratings-Low-Rating-Headroom-for-Pharma-Issuers-in-2019-1050354_pr_frame>

APA:	Fitch Research. (). Fitch Ratings: Low Rating Headroom for Pharma Issuers in 2019 Nov 26, 2018. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Ratings-Low-Rating-Headroom-for-Pharma-Issuers-in-2019-1050354_pr_frame>

US$ 149.00

$ £ €

Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

Example Report

Click to View Sample Report

More Research

Search all our Credit Research from one place.